1Inflammation Research Center, VIB, Ghent, Belgium.
2Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
3Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.
4Department of Management, Technology and Economics, ETH Zurich, Zurich, Switzerland.
5Center for Neurogenomics and Cognitive Research, VU University Amsterdam, Amsterdam, The Netherlands.
* See also p. 1964.
Drs. Brouckaert and Cauwels share senior authorship.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Supported, in part, by the agency for Innovation by Science and Technology, Research Foundation Flanders, and Ghent University: Concerted Research Actions.
Mr. Vandendriessche received grant support from the agency for Innovation by Science and Technology (PhD fellowship). Dr. Hoste lectured for Astute Medical, Pfizer, and Gambro and received support for travel from European Society of Intensive Care Medicine, Vicenza Critical Care Nephrology, International Symposium on Intensive Care and Emergency Medicine, and Acute Dialysis Quality Initiative. His institution received grant support from the Industrial Research Fund and Ghent University (grant for clinical validation of a biomarker for acute kidney injury). The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]
